id	sid	tid	token	lemma	pos
dpc-4292	1	1	dermatology	dermatology	NOUN
dpc-4292	1	2	:	:	PUNCT
dpc-4292	1	3	practical	practical	ADJ
dpc-4292	1	4	and	and	CCONJ
dpc-4292	1	5	conceptual	conceptual	ADJ
dpc-4292	1	6	research	research	NOUN
dpc-4292	1	7	letter	letter	NOUN
dpc-4292	2	1	|	|	ADV
dpc-4292	2	2	dermatol	dermatol	ADJ
dpc-4292	2	3	pract	pract	NOUN
dpc-4292	2	4	concept	concept	NOUN
dpc-4292	2	5	.	.	PUNCT
dpc-4292	3	1	2024;14(3):e2024201	2024;14(3):e2024201	NUM
dpc-4292	3	2	1	1	NUM
dpc-4292	3	3	topical	topical	ADJ
dpc-4292	3	4	sirolimus	sirolimus	NOUN
dpc-4292	3	5	0.1	0.1	NUM
dpc-4292	3	6	%	%	NOUN
dpc-4292	3	7	as	as	ADP
dpc-4292	3	8	off	off	ADP
dpc-4292	3	9	-	-	PUNCT
dpc-4292	3	10	label	label	NOUN
dpc-4292	3	11	treatment	treatment	NOUN
dpc-4292	3	12	of	of	ADP
dpc-4292	3	13	kaposi	kaposi	PROPN
dpc-4292	3	14	’s	’s	PART
dpc-4292	3	15	sarcoma	sarcoma	PROPN
dpc-4292	3	16	vittorio	vittorio	PROPN
dpc-4292	3	17	tancredi1	tancredi1	PROPN
dpc-4292	3	18	,	,	PUNCT
dpc-4292	3	19	gaetano	gaetano	PROPN
dpc-4292	3	20	licata2	licata2	PROPN
dpc-4292	3	21	,	,	PUNCT
dpc-4292	3	22	dario	dario	PROPN
dpc-4292	3	23	buononato1	buononato1	PROPN
dpc-4292	3	24	,	,	PUNCT
dpc-4292	3	25	maria	maria	PROPN
dpc-4292	3	26	pia	pia	PROPN
dpc-4292	3	27	boccellino1	boccellino1	PROPN
dpc-4292	3	28	,	,	PUNCT
dpc-4292	3	29	giuseppe	giuseppe	PROPN
dpc-4292	3	30	argenziano1	argenziano1	PROPN
dpc-4292	3	31	,	,	PUNCT
dpc-4292	3	32	caterina	caterina	PROPN
dpc-4292	3	33	mariarosaria	mariarosaria	PROPN
dpc-4292	3	34	giorgio1	giorgio1	PROPN
dpc-4292	3	35	1	1	NUM
dpc-4292	3	36	dermatology	dermatology	NOUN
dpc-4292	3	37	unit	unit	NOUN
dpc-4292	3	38	,	,	PUNCT
dpc-4292	3	39	department	department	NOUN
dpc-4292	3	40	of	of	ADP
dpc-4292	3	41	mental	mental	ADJ
dpc-4292	3	42	and	and	CCONJ
dpc-4292	3	43	physical	physical	ADJ
dpc-4292	3	44	health	health	NOUN
dpc-4292	3	45	and	and	CCONJ
dpc-4292	3	46	preventive	preventive	ADJ
dpc-4292	3	47	medicine	medicine	NOUN
dpc-4292	3	48	,	,	PUNCT
dpc-4292	3	49	university	university	PROPN
dpc-4292	3	50	of	of	ADP
dpc-4292	3	51	campania	campania	PROPN
dpc-4292	3	52	luigi	luigi	PROPN
dpc-4292	3	53	vanvitelli	vanvitelli	PROPN
dpc-4292	3	54	,	,	PUNCT
dpc-4292	3	55	naples	naples	PROPN
dpc-4292	3	56	,	,	PUNCT
dpc-4292	3	57	italy	italy	PROPN
dpc-4292	3	58	2	2	NUM
dpc-4292	3	59	dermatology	dermatology	NOUN
dpc-4292	3	60	unit	unit	NOUN
dpc-4292	3	61	,	,	PUNCT
dpc-4292	3	62	san	san	PROPN
dpc-4292	3	63	antonio	antonio	PROPN
dpc-4292	3	64	abate	abate	VERB
dpc-4292	3	65	hospital	hospital	NOUN
dpc-4292	3	66	,	,	PUNCT
dpc-4292	3	67	trapani	trapani	X
dpc-4292	3	68	,	,	PUNCT
dpc-4292	3	69	italy	italy	PROPN
dpc-4292	3	70	key	key	ADJ
dpc-4292	3	71	words	word	NOUN
dpc-4292	3	72	:	:	PUNCT
dpc-4292	3	73	sirolimus	sirolimus	NOUN
dpc-4292	3	74	,	,	PUNCT
dpc-4292	3	75	kaposi	kaposi	PROPN
dpc-4292	3	76	,	,	PUNCT
dpc-4292	3	77	angiogenesis	angiogenesis	NOUN
dpc-4292	3	78	citation	citation	NOUN
dpc-4292	3	79	:	:	PUNCT
dpc-4292	3	80	tancredi	tancredi	NOUN
dpc-4292	3	81	v	v	NOUN
dpc-4292	3	82	,	,	PUNCT
dpc-4292	3	83	licata	licata	VERB
dpc-4292	3	84	g	g	NOUN
dpc-4292	3	85	,	,	PUNCT
dpc-4292	3	86	buononato	buononato	NOUN
dpc-4292	3	87	d	d	NOUN
dpc-4292	3	88	,	,	PUNCT
dpc-4292	3	89	boccellino	boccellino	PROPN
dpc-4292	3	90	mp	mp	PROPN
dpc-4292	3	91	,	,	PUNCT
dpc-4292	3	92	argenziano	argenziano	VERB
dpc-4292	3	93	g	g	PROPN
dpc-4292	3	94	,	,	PUNCT
dpc-4292	3	95	giorgio	giorgio	PROPN
dpc-4292	3	96	cm	cm	NOUN
dpc-4292	3	97	.	.	PUNCT
dpc-4292	4	1	topical	topical	ADJ
dpc-4292	4	2	sirolimus	sirolimus	NOUN
dpc-4292	4	3	0.1	0.1	NUM
dpc-4292	4	4	%	%	NOUN
dpc-4292	4	5	as	as	ADP
dpc-4292	4	6	off	off	ADP
dpc-4292	4	7	label	label	NOUN
dpc-4292	4	8	treatment	treatment	NOUN
dpc-4292	4	9	of	of	ADP
dpc-4292	4	10	kaposi	kaposi	PROPN
dpc-4292	4	11	’s	’s	PART
dpc-4292	4	12	sarcoma	sarcoma	NOUN
dpc-4292	4	13	.	.	PUNCT
dpc-4292	5	1	dermatol	dermatol	NOUN
dpc-4292	5	2	pract	pract	PROPN
dpc-4292	5	3	concept	concept	NOUN
dpc-4292	5	4	.	.	PUNCT
dpc-4292	6	1	2024;14(3):e2024201	2024;14(3):e2024201	NUM
dpc-4292	6	2	.	.	PUNCT
dpc-4292	6	3	doi	doi	NOUN
dpc-4292	6	4	:	:	PUNCT
dpc-4292	6	5	https://doi.org/10.5826/dpc.1403a201	https://doi.org/10.5826/dpc.1403a201	PROPN
dpc-4292	6	6	accepted	accept	VERB
dpc-4292	6	7	:	:	PUNCT
dpc-4292	6	8	february	february	PROPN
dpc-4292	6	9	19	19	NUM
dpc-4292	6	10	,	,	PUNCT
dpc-4292	6	11	2024	2024	NUM
dpc-4292	6	12	;	;	PUNCT
dpc-4292	6	13	published	publish	VERB
dpc-4292	6	14	:	:	PUNCT
dpc-4292	7	1	july	july	PROPN
dpc-4292	7	2	2024	2024	NUM
dpc-4292	7	3	copyright	copyright	NOUN
dpc-4292	7	4	:	:	PUNCT
dpc-4292	7	5	©	©	PROPN
dpc-4292	7	6	tancredi	tancredi	NOUN
dpc-4292	7	7	et	et	PROPN
dpc-4292	7	8	al	al	PROPN
dpc-4292	7	9	.	.	PUNCT
dpc-4292	8	1	this	this	PRON
dpc-4292	8	2	is	be	AUX
dpc-4292	8	3	an	an	DET
dpc-4292	8	4	open	open	ADJ
dpc-4292	8	5	-	-	PUNCT
dpc-4292	8	6	access	access	NOUN
dpc-4292	8	7	article	article	NOUN
dpc-4292	8	8	distributed	distribute	VERB
dpc-4292	8	9	under	under	ADP
dpc-4292	8	10	the	the	DET
dpc-4292	8	11	terms	term	NOUN
dpc-4292	8	12	of	of	ADP
dpc-4292	8	13	the	the	DET
dpc-4292	8	14	creative	creative	ADJ
dpc-4292	8	15	commons	common	NOUN
dpc-4292	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4292	8	17	license	license	NOUN
dpc-4292	8	18	(	(	PUNCT
dpc-4292	8	19	by	by	ADP
dpc-4292	8	20	-	-	PUNCT
dpc-4292	8	21	nc-4.0	nc-4.0	NOUN
dpc-4292	8	22	)	)	PUNCT
dpc-4292	8	23	,	,	PUNCT
dpc-4292	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4292	8	25	,	,	PUNCT
dpc-4292	8	26	which	which	PRON
dpc-4292	8	27	permits	permit	VERB
dpc-4292	8	28	unrestricted	unrestricted	ADJ
dpc-4292	8	29	noncommercial	noncommercial	ADJ
dpc-4292	8	30	use	use	NOUN
dpc-4292	8	31	,	,	PUNCT
dpc-4292	8	32	distribution	distribution	NOUN
dpc-4292	8	33	,	,	PUNCT
dpc-4292	8	34	and	and	CCONJ
dpc-4292	8	35	reproduction	reproduction	NOUN
dpc-4292	8	36	in	in	ADP
dpc-4292	8	37	any	any	DET
dpc-4292	8	38	medium	medium	NOUN
dpc-4292	8	39	,	,	PUNCT
dpc-4292	8	40	provided	provide	VERB
dpc-4292	8	41	the	the	DET
dpc-4292	8	42	original	original	ADJ
dpc-4292	8	43	authors	author	NOUN
dpc-4292	8	44	and	and	CCONJ
dpc-4292	8	45	source	source	NOUN
dpc-4292	8	46	are	be	AUX
dpc-4292	8	47	credited	credit	VERB
dpc-4292	8	48	.	.	PUNCT
dpc-4292	9	1	funding	funding	NOUN
dpc-4292	9	2	:	:	PUNCT
dpc-4292	9	3	none	none	NOUN
dpc-4292	9	4	.	.	PUNCT
dpc-4292	10	1	competing	compete	VERB
dpc-4292	10	2	interests	interest	NOUN
dpc-4292	10	3	:	:	PUNCT
dpc-4292	10	4	none	none	NOUN
dpc-4292	10	5	.	.	PUNCT
dpc-4292	11	1	authorship	authorship	NOUN
dpc-4292	11	2	:	:	PUNCT
dpc-4292	11	3	all	all	DET
dpc-4292	11	4	authors	author	NOUN
dpc-4292	11	5	have	have	AUX
dpc-4292	11	6	contributed	contribute	VERB
dpc-4292	11	7	significantly	significantly	ADV
dpc-4292	11	8	to	to	ADP
dpc-4292	11	9	this	this	DET
dpc-4292	11	10	publication	publication	NOUN
dpc-4292	11	11	.	.	PUNCT
dpc-4292	12	1	corresponding	correspond	VERB
dpc-4292	12	2	author	author	NOUN
dpc-4292	12	3	:	:	PUNCT
dpc-4292	12	4	gaetano	gaetano	PROPN
dpc-4292	12	5	licata	licata	PROPN
dpc-4292	12	6	,	,	PUNCT
dpc-4292	12	7	md	md	PROPN
dpc-4292	12	8	,	,	PUNCT
dpc-4292	12	9	dermatology	dermatology	NOUN
dpc-4292	12	10	unit	unit	NOUN
dpc-4292	12	11	,	,	PUNCT
dpc-4292	12	12	san	san	PROPN
dpc-4292	12	13	antonio	antonio	PROPN
dpc-4292	12	14	abate	abate	VERB
dpc-4292	12	15	hospital	hospital	NOUN
dpc-4292	12	16	,	,	PUNCT
dpc-4292	12	17	via	via	ADP
dpc-4292	12	18	cosenza	cosenza	PROPN
dpc-4292	12	19	82	82	NUM
dpc-4292	12	20	,	,	PUNCT
dpc-4292	12	21	91016	91016	NUM
dpc-4292	12	22	,	,	PUNCT
dpc-4292	12	23	erice	erice	NOUN
dpc-4292	12	24	(	(	PUNCT
dpc-4292	12	25	tp	tp	NOUN
dpc-4292	12	26	)	)	PUNCT
dpc-4292	12	27	,	,	PUNCT
dpc-4292	12	28	italy	italy	PROPN
dpc-4292	12	29	.	.	PUNCT
dpc-4292	13	1	phone	phone	NOUN
dpc-4292	13	2	:	:	PUNCT
dpc-4292	13	3	3276215976	3276215976	NUM
dpc-4292	13	4	,	,	PUNCT
dpc-4292	13	5	email	email	NOUN
dpc-4292	13	6	:	:	PUNCT
dpc-4292	13	7	gaetano.licata89@gmail.com	gaetano.licata89@gmail.com	PROPN
dpc-4292	13	8	introduction	introduction	PROPN
dpc-4292	13	9	kaposi	kaposi	PROPN
dpc-4292	13	10	’s	’s	PART
dpc-4292	13	11	sarcoma	sarcoma	NOUN
dpc-4292	13	12	(	(	PUNCT
dpc-4292	13	13	ks	ks	NOUN
dpc-4292	13	14	,	,	PUNCT
dpc-4292	13	15	now	now	ADV
dpc-4292	13	16	more	more	ADV
dpc-4292	13	17	precisely	precisely	ADV
dpc-4292	13	18	referred	refer	VERB
dpc-4292	13	19	to	to	ADP
dpc-4292	13	20	as	as	ADP
dpc-4292	13	21	kaposi	kaposi	PROPN
dpc-4292	13	22	’s	’s	PART
dpc-4292	13	23	disease	disease	NOUN
dpc-4292	13	24	)	)	PUNCT
dpc-4292	13	25	is	be	AUX
dpc-4292	13	26	a	a	DET
dpc-4292	13	27	vascular	vascular	ADJ
dpc-4292	13	28	proliferative	proliferative	ADJ
dpc-4292	13	29	disorder	disorder	NOUN
dpc-4292	13	30	associated	associate	VERB
dpc-4292	13	31	with	with	ADP
dpc-4292	13	32	human	human	ADJ
dpc-4292	13	33	herpesvirus	herpesvirus	NOUN
dpc-4292	13	34	8	8	NUM
dpc-4292	13	35	(	(	PUNCT
dpc-4292	13	36	hhv8	hhv8	PROPN
dpc-4292	13	37	)	)	PUNCT
dpc-4292	13	38	infection	infection	NOUN
dpc-4292	13	39	.	.	PUNCT
dpc-4292	14	1	its	its	PRON
dpc-4292	14	2	classical	classical	ADJ
dpc-4292	14	3	form	form	NOUN
dpc-4292	14	4	,	,	PUNCT
dpc-4292	14	5	mediterranean	mediterranean	PROPN
dpc-4292	14	6	kaposi	kaposi	PROPN
dpc-4292	14	7	,	,	PUNCT
dpc-4292	14	8	is	be	AUX
dpc-4292	14	9	characterized	characterize	VERB
dpc-4292	14	10	by	by	ADP
dpc-4292	14	11	multiple	multiple	ADJ
dpc-4292	14	12	red	red	ADJ
dpc-4292	14	13	-	-	PUNCT
dpc-4292	14	14	purple	purple	ADJ
dpc-4292	14	15	macules	macule	NOUN
dpc-4292	14	16	,	,	PUNCT
dpc-4292	14	17	patches	patch	NOUN
dpc-4292	14	18	,	,	PUNCT
dpc-4292	14	19	and	and	CCONJ
dpc-4292	14	20	nodules	nodule	NOUN
dpc-4292	14	21	typically	typically	ADV
dpc-4292	14	22	involving	involve	VERB
dpc-4292	14	23	the	the	DET
dpc-4292	14	24	lower	low	ADJ
dpc-4292	14	25	limbs	limb	NOUN
dpc-4292	14	26	of	of	ADP
dpc-4292	14	27	elderly	elderly	ADJ
dpc-4292	14	28	subjects	subject	NOUN
dpc-4292	14	29	.	.	PUNCT
dpc-4292	15	1	management	management	NOUN
dpc-4292	15	2	of	of	ADP
dpc-4292	15	3	these	these	DET
dpc-4292	15	4	patients	patient	NOUN
dpc-4292	15	5	can	can	AUX
dpc-4292	15	6	be	be	AUX
dpc-4292	15	7	challenging	challenge	VERB
dpc-4292	15	8	.	.	PUNCT
dpc-4292	16	1	therapeutic	therapeutic	ADJ
dpc-4292	16	2	options	option	NOUN
dpc-4292	16	3	depend	depend	VERB
dpc-4292	16	4	on	on	ADP
dpc-4292	16	5	various	various	ADJ
dpc-4292	16	6	factors	factor	NOUN
dpc-4292	16	7	such	such	ADJ
dpc-4292	16	8	as	as	ADP
dpc-4292	16	9	the	the	DET
dpc-4292	16	10	number	number	NOUN
dpc-4292	16	11	and	and	CCONJ
dpc-4292	16	12	types	type	NOUN
dpc-4292	16	13	of	of	ADP
dpc-4292	16	14	lesions	lesion	NOUN
dpc-4292	16	15	,	,	PUNCT
dpc-4292	16	16	the	the	DET
dpc-4292	16	17	presence	presence	NOUN
dpc-4292	16	18	of	of	ADP
dpc-4292	16	19	lymphedema	lymphedema	NOUN
dpc-4292	16	20	,	,	PUNCT
dpc-4292	16	21	age	age	NOUN
dpc-4292	16	22	,	,	PUNCT
dpc-4292	16	23	immunosuppression	immunosuppression	NOUN
dpc-4292	16	24	,	,	PUNCT
dpc-4292	16	25	patients	patient	NOUN
dpc-4292	16	26	’	'	PUNCT
dpc-4292	16	27	compliance	compliance	NOUN
dpc-4292	16	28	,	,	PUNCT
dpc-4292	16	29	and	and	CCONJ
dpc-4292	16	30	so	so	ADV
dpc-4292	16	31	on	on	ADV
dpc-4292	16	32	.	.	PUNCT
dpc-4292	17	1	for	for	ADP
dpc-4292	17	2	skin	skin	NOUN
dpc-4292	17	3	-	-	PUNCT
dpc-4292	17	4	limited	limit	VERB
dpc-4292	17	5	ks	ks	NOUN
dpc-4292	17	6	,	,	PUNCT
dpc-4292	17	7	shaving	shaving	NOUN
dpc-4292	17	8	or	or	CCONJ
dpc-4292	17	9	cryotherapy	cryotherapy	NOUN
dpc-4292	17	10	is	be	AUX
dpc-4292	17	11	an	an	DET
dpc-4292	17	12	option	option	NOUN
dpc-4292	17	13	for	for	ADP
dpc-4292	17	14	small	small	ADJ
dpc-4292	17	15	macules	macule	NOUN
dpc-4292	17	16	or	or	CCONJ
dpc-4292	17	17	nodules	nodule	NOUN
dpc-4292	17	18	,	,	PUNCT
dpc-4292	17	19	while	while	SCONJ
dpc-4292	17	20	the	the	DET
dpc-4292	17	21	treatment	treatment	NOUN
dpc-4292	17	22	of	of	ADP
dpc-4292	17	23	large	large	ADJ
dpc-4292	17	24	patches	patch	NOUN
dpc-4292	17	25	and	and	CCONJ
dpc-4292	17	26	plaques	plaque	NOUN
dpc-4292	17	27	is	be	AUX
dpc-4292	17	28	more	more	ADV
dpc-4292	17	29	complex	complex	ADJ
dpc-4292	17	30	.	.	PUNCT
dpc-4292	18	1	many	many	ADJ
dpc-4292	18	2	topical	topical	ADJ
dpc-4292	18	3	and	and	CCONJ
dpc-4292	18	4	systemic	systemic	ADJ
dpc-4292	18	5	approaches	approach	NOUN
dpc-4292	18	6	have	have	AUX
dpc-4292	18	7	been	be	AUX
dpc-4292	18	8	evaluated	evaluate	VERB
dpc-4292	18	9	,	,	PUNCT
dpc-4292	18	10	from	from	ADP
dpc-4292	18	11	elastic	elastic	ADJ
dpc-4292	18	12	stocking	stocking	NOUN
dpc-4292	18	13	to	to	ADP
dpc-4292	18	14	beta	beta	ADJ
dpc-4292	18	15	blockers	blocker	NOUN
dpc-4292	18	16	,	,	PUNCT
dpc-4292	18	17	intra	intra	ADJ
dpc-4292	18	18	-	-	ADJ
dpc-4292	18	19	lesional	lesional	ADJ
dpc-4292	18	20	chemotherapeutic	chemotherapeutic	ADJ
dpc-4292	18	21	agents	agent	NOUN
dpc-4292	18	22	like	like	ADP
dpc-4292	18	23	vinblastine	vinblastine	NOUN
dpc-4292	18	24	and	and	CCONJ
dpc-4292	18	25	bleomycin	bleomycin	PROPN
dpc-4292	18	26	,	,	PUNCT
dpc-4292	18	27	electrochemotherapy	electrochemotherapy	NOUN
dpc-4292	18	28	,	,	PUNCT
dpc-4292	18	29	and	and	CCONJ
dpc-4292	18	30	so	so	ADV
dpc-4292	18	31	on	on	ADP
dpc-4292	18	32	[	[	X
dpc-4292	18	33	1	1	NUM
dpc-4292	18	34	]	]	PUNCT
dpc-4292	18	35	.	.	PUNCT
dpc-4292	19	1	case	case	NOUN
dpc-4292	19	2	presentation	presentation	NOUN
dpc-4292	19	3	in	in	ADP
dpc-4292	19	4	our	our	PRON
dpc-4292	19	5	dermatology	dermatology	NOUN
dpc-4292	19	6	department	department	NOUN
dpc-4292	19	7	,	,	PUNCT
dpc-4292	19	8	we	we	PRON
dpc-4292	19	9	treated	treat	VERB
dpc-4292	19	10	thirteen	thirteen	NUM
dpc-4292	19	11	patients	patient	NOUN
dpc-4292	19	12	with	with	ADP
dpc-4292	19	13	classical	classical	ADJ
dpc-4292	19	14	ks	k	NOUN
dpc-4292	19	15	,	,	PUNCT
dpc-4292	19	16	mostly	mostly	ADV
dpc-4292	19	17	represented	represent	VERB
dpc-4292	19	18	by	by	ADP
dpc-4292	19	19	large	large	ADJ
dpc-4292	19	20	patches	patch	NOUN
dpc-4292	19	21	and	and	CCONJ
dpc-4292	19	22	plaques	plaque	NOUN
dpc-4292	19	23	on	on	ADP
dpc-4292	19	24	the	the	DET
dpc-4292	19	25	lower	low	ADJ
dpc-4292	19	26	limbs	limb	NOUN
dpc-4292	19	27	,	,	PUNCT
dpc-4292	19	28	using	use	VERB
dpc-4292	19	29	topical	topical	ADJ
dpc-4292	19	30	galenic	galenic	ADJ
dpc-4292	19	31	sirolimus	sirolimus	NOUN
dpc-4292	19	32	(	(	PUNCT
dpc-4292	19	33	0.1	0.1	NUM
dpc-4292	19	34	%	%	NOUN
dpc-4292	19	35	in	in	ADP
dpc-4292	19	36	pentravan	pentravan	NOUN
dpc-4292	19	37	®	®	NOUN
dpc-4292	19	38	)	)	PUNCT
dpc-4292	19	39	twice	twice	ADV
dpc-4292	19	40	daily	daily	ADV
dpc-4292	19	41	.	.	PUNCT
dpc-4292	20	1	the	the	DET
dpc-4292	20	2	diagnosis	diagnosis	NOUN
dpc-4292	20	3	was	be	AUX
dpc-4292	20	4	confirmed	confirm	VERB
dpc-4292	20	5	by	by	ADP
dpc-4292	20	6	a	a	DET
dpc-4292	20	7	punch	punch	NOUN
dpc-4292	20	8	biopsy	biopsy	NOUN
dpc-4292	20	9	in	in	ADP
dpc-4292	20	10	all	all	DET
dpc-4292	20	11	patients	patient	NOUN
dpc-4292	20	12	.	.	PUNCT
dpc-4292	21	1	since	since	SCONJ
dpc-4292	21	2	june	june	PROPN
dpc-4292	21	3	2023	2023	NUM
dpc-4292	21	4	,	,	PUNCT
dpc-4292	21	5	thirteen	thirteen	NUM
dpc-4292	21	6	patients	patient	NOUN
dpc-4292	21	7	(	(	PUNCT
dpc-4292	21	8	eight	eight	NUM
dpc-4292	21	9	males	male	NOUN
dpc-4292	21	10	and	and	CCONJ
dpc-4292	21	11	five	five	NUM
dpc-4292	21	12	females	female	NOUN
dpc-4292	21	13	,	,	PUNCT
dpc-4292	21	14	mean	mean	VERB
dpc-4292	21	15	age	age	NOUN
dpc-4292	21	16	81.6	81.6	NUM
dpc-4292	21	17	)	)	PUNCT
dpc-4292	21	18	have	have	AUX
dpc-4292	21	19	been	be	AUX
dpc-4292	21	20	under	under	ADP
dpc-4292	21	21	treatment	treatment	NOUN
dpc-4292	21	22	.	.	PUNCT
dpc-4292	22	1	the	the	DET
dpc-4292	22	2	lesions	lesion	NOUN
dpc-4292	22	3	mainly	mainly	ADV
dpc-4292	22	4	consisted	consist	VERB
dpc-4292	22	5	in	in	ADP
dpc-4292	22	6	large	large	ADJ
dpc-4292	22	7	plaques	plaque	NOUN
dpc-4292	22	8	.	.	PUNCT
dpc-4292	23	1	they	they	PRON
dpc-4292	23	2	were	be	AUX
dpc-4292	23	3	previously	previously	ADV
dpc-4292	23	4	treated	treat	VERB
dpc-4292	23	5	with	with	ADP
dpc-4292	23	6	elastic	elastic	ADJ
dpc-4292	23	7	compression	compression	NOUN
dpc-4292	23	8	without	without	ADP
dpc-4292	23	9	significant	significant	ADJ
dpc-4292	23	10	benefits	benefit	NOUN
dpc-4292	23	11	.	.	PUNCT
dpc-4292	24	1	none	none	NOUN
dpc-4292	24	2	of	of	ADP
dpc-4292	24	3	them	they	PRON
dpc-4292	24	4	was	be	AUX
dpc-4292	24	5	on	on	ADP
dpc-4292	24	6	beta	beta	ADJ
dpc-4292	24	7	blockers	blocker	NOUN
dpc-4292	24	8	for	for	ADP
dpc-4292	24	9	other	other	ADJ
dpc-4292	24	10	diseases	disease	NOUN
dpc-4292	24	11	.	.	PUNCT
dpc-4292	25	1	after	after	ADP
dpc-4292	25	2	three	three	NUM
dpc-4292	25	3	months	month	NOUN
dpc-4292	25	4	,	,	PUNCT
dpc-4292	25	5	the	the	DET
dpc-4292	25	6	lesions	lesion	NOUN
dpc-4292	25	7	showed	show	VERB
dpc-4292	25	8	a	a	DET
dpc-4292	25	9	significant	significant	ADJ
dpc-4292	25	10	reduction	reduction	NOUN
dpc-4292	25	11	in	in	ADP
dpc-4292	25	12	skin	skin	NOUN
dpc-4292	25	13	infiltration	infiltration	NOUN
dpc-4292	25	14	,	,	PUNCT
dpc-4292	25	15	and	and	CCONJ
dpc-4292	25	16	after	after	ADP
dpc-4292	25	17	six	six	NUM
dpc-4292	25	18	months	month	NOUN
dpc-4292	25	19	,	,	PUNCT
dpc-4292	25	20	some	some	PRON
dpc-4292	25	21	of	of	ADP
dpc-4292	25	22	the	the	DET
dpc-4292	25	23	smallest	small	ADJ
dpc-4292	25	24	ones	one	NOUN
dpc-4292	25	25	had	have	AUX
dpc-4292	25	26	almost	almost	ADV
dpc-4292	25	27	disappeared	disappear	VERB
dpc-4292	25	28	.	.	PUNCT
dpc-4292	26	1	only	only	ADV
dpc-4292	26	2	two	two	NUM
dpc-4292	26	3	patient	patient	NOUN
dpc-4292	26	4	did	do	AUX
dpc-4292	26	5	not	not	PART
dpc-4292	26	6	show	show	VERB
dpc-4292	26	7	any	any	DET
dpc-4292	26	8	benefit	benefit	NOUN
dpc-4292	26	9	.	.	PUNCT
dpc-4292	27	1	the	the	DET
dpc-4292	27	2	patients	patient	NOUN
dpc-4292	27	3	are	be	AUX
dpc-4292	27	4	still	still	ADV
dpc-4292	27	5	under	under	ADP
dpc-4292	27	6	treatment	treatment	NOUN
dpc-4292	27	7	,	,	PUNCT
dpc-4292	27	8	without	without	ADP
dpc-4292	27	9	any	any	DET
dpc-4292	27	10	significant	significant	ADJ
dpc-4292	27	11	adverse	adverse	ADJ
dpc-4292	27	12	events	event	NOUN
dpc-4292	27	13	(	(	PUNCT
dpc-4292	27	14	figure	figure	NOUN
dpc-4292	27	15	1	1	NUM
dpc-4292	27	16	)	)	PUNCT
dpc-4292	27	17	.	.	PUNCT
dpc-4292	28	1	2	2	NUM
dpc-4292	28	2	research	research	NOUN
dpc-4292	28	3	letter	letter	NOUN
dpc-4292	28	4	|	|	ADV
dpc-4292	28	5	dermatol	dermatol	ADJ
dpc-4292	28	6	pract	pract	NOUN
dpc-4292	28	7	concept	concept	NOUN
dpc-4292	28	8	.	.	PUNCT
dpc-4292	29	1	2024;14(3):e2024201	2024;14(3):e2024201	NUM
dpc-4292	29	2	conclusion	conclusion	NOUN
dpc-4292	29	3	sirolimus	sirolimus	NOUN
dpc-4292	29	4	targets	target	NOUN
dpc-4292	29	5	a	a	DET
dpc-4292	29	6	serine	serine	ADJ
dpc-4292	29	7	threonine	threonine	ADJ
dpc-4292	29	8	kinase	kinase	NOUN
dpc-4292	29	9	known	know	VERB
dpc-4292	29	10	as	as	ADP
dpc-4292	29	11	mtor	mtor	NOUN
dpc-4292	29	12	(	(	PUNCT
dpc-4292	29	13	mammalian	mammalian	ADJ
dpc-4292	29	14	target	target	NOUN
dpc-4292	29	15	of	of	ADP
dpc-4292	29	16	rapamycin	rapamycin	NOUN
dpc-4292	29	17	)	)	PUNCT
dpc-4292	29	18	,	,	PUNCT
dpc-4292	29	19	which	which	PRON
dpc-4292	29	20	plays	play	VERB
dpc-4292	29	21	a	a	DET
dpc-4292	29	22	crucial	crucial	ADJ
dpc-4292	29	23	role	role	NOUN
dpc-4292	29	24	in	in	ADP
dpc-4292	29	25	regulating	regulate	VERB
dpc-4292	29	26	cell	cell	NOUN
dpc-4292	29	27	growth	growth	NOUN
dpc-4292	29	28	,	,	PUNCT
dpc-4292	29	29	proliferation	proliferation	NOUN
dpc-4292	29	30	,	,	PUNCT
dpc-4292	29	31	and	and	CCONJ
dpc-4292	29	32	survival	survival	NOUN
dpc-4292	29	33	.	.	PUNCT
dpc-4292	30	1	for	for	ADP
dpc-4292	30	2	this	this	DET
dpc-4292	30	3	reason	reason	NOUN
dpc-4292	30	4	,	,	PUNCT
dpc-4292	30	5	several	several	ADJ
dpc-4292	30	6	novel	novel	ADJ
dpc-4292	30	7	anticancer	anticancer	NOUN
dpc-4292	30	8	drugs	drug	NOUN
dpc-4292	30	9	aim	aim	VERB
dpc-4292	30	10	to	to	PART
dpc-4292	30	11	inhibit	inhibit	VERB
dpc-4292	30	12	this	this	DET
dpc-4292	30	13	enzyme	enzyme	NOUN
dpc-4292	30	14	.	.	PUNCT
dpc-4292	31	1	growth	growth	NOUN
dpc-4292	31	2	factors	factor	NOUN
dpc-4292	31	3	like	like	ADP
dpc-4292	31	4	igf	igf	PROPN
dpc-4292	31	5	(	(	PUNCT
dpc-4292	31	6	insulin	insulin	NOUN
dpc-4292	31	7	-	-	PUNCT
dpc-4292	31	8	like	like	ADJ
dpc-4292	31	9	growth	growth	NOUN
dpc-4292	31	10	factor	factor	NOUN
dpc-4292	31	11	)	)	PUNCT
dpc-4292	31	12	,	,	PUNCT
dpc-4292	31	13	egf	egf	PROPN
dpc-4292	31	14	(	(	PUNCT
dpc-4292	31	15	epidermal	epidermal	ADJ
dpc-4292	31	16	growth	growth	NOUN
dpc-4292	31	17	factor	factor	NOUN
dpc-4292	31	18	)	)	PUNCT
dpc-4292	31	19	,	,	PUNCT
dpc-4292	31	20	pdgf	pdgf	NOUN
dpc-4292	31	21	(	(	PUNCT
dpc-4292	31	22	platelet	platelet	NOUN
dpc-4292	31	23	-	-	PUNCT
dpc-4292	31	24	derived	derive	VERB
dpc-4292	31	25	growth	growth	NOUN
dpc-4292	31	26	factor	factor	NOUN
dpc-4292	31	27	)	)	PUNCT
dpc-4292	31	28	,	,	PUNCT
dpc-4292	31	29	and	and	CCONJ
dpc-4292	31	30	vegf	vegf	PROPN
dpc-4292	31	31	(	(	PUNCT
dpc-4292	31	32	vascular	vascular	ADJ
dpc-4292	31	33	endothelial	endothelial	ADJ
dpc-4292	31	34	growth	growth	NOUN
dpc-4292	31	35	factor	factor	NOUN
dpc-4292	31	36	)	)	PUNCT
dpc-4292	31	37	bind	bind	VERB
dpc-4292	31	38	and	and	CCONJ
dpc-4292	31	39	activate	activate	VERB
dpc-4292	31	40	receptors	receptor	NOUN
dpc-4292	31	41	on	on	ADP
dpc-4292	31	42	the	the	DET
dpc-4292	31	43	cell	cell	NOUN
dpc-4292	31	44	surface	surface	NOUN
dpc-4292	31	45	,	,	PUNCT
dpc-4292	31	46	initiating	initiate	VERB
dpc-4292	31	47	a	a	DET
dpc-4292	31	48	cascade	cascade	NOUN
dpc-4292	31	49	of	of	ADP
dpc-4292	31	50	intracellular	intracellular	ADJ
dpc-4292	31	51	pathways	pathway	NOUN
dpc-4292	31	52	mediated	mediate	VERB
dpc-4292	31	53	by	by	ADP
dpc-4292	31	54	mtor	mtor	NOUN
dpc-4292	31	55	.	.	PUNCT
dpc-4292	32	1	thus	thus	ADV
dpc-4292	32	2	,	,	PUNCT
dpc-4292	32	3	increased	increase	VERB
dpc-4292	32	4	activity	activity	NOUN
dpc-4292	32	5	of	of	ADP
dpc-4292	32	6	mtor	mtor	NOUN
dpc-4292	32	7	can	can	AUX
dpc-4292	32	8	alter	alter	VERB
dpc-4292	32	9	metabolic	metabolic	NOUN
dpc-4292	32	10	pathways	pathway	NOUN
dpc-4292	32	11	,	,	PUNCT
dpc-4292	32	12	increasing	increase	VERB
dpc-4292	32	13	the	the	DET
dpc-4292	32	14	risk	risk	NOUN
dpc-4292	32	15	of	of	ADP
dpc-4292	32	16	tumor	tumor	NOUN
dpc-4292	32	17	development	development	NOUN
dpc-4292	32	18	and	and	CCONJ
dpc-4292	32	19	neo	neo	NOUN
dpc-4292	32	20	-	-	NOUN
dpc-4292	32	21	angiogenesis	angiogenesis	NOUN
dpc-4292	32	22	.	.	PUNCT
dpc-4292	33	1	hhv-8	hhv-8	NOUN
dpc-4292	33	2	genes	gene	NOUN
dpc-4292	33	3	like	like	ADP
dpc-4292	33	4	orf	orf	NOUN
dpc-4292	33	5	-	-	PUNCT
dpc-4292	33	6	k1	k1	NOUN
dpc-4292	33	7	and	and	CCONJ
dpc-4292	33	8	orf	orf	PROPN
dpc-4292	33	9	-	-	PUNCT
dpc-4292	33	10	k15	k15	PROPN
dpc-4292	33	11	are	be	AUX
dpc-4292	33	12	able	able	ADJ
dpc-4292	33	13	to	to	PART
dpc-4292	33	14	increase	increase	VERB
dpc-4292	33	15	the	the	DET
dpc-4292	33	16	levels	level	NOUN
dpc-4292	33	17	of	of	ADP
dpc-4292	33	18	pro	pro	ADJ
dpc-4292	33	19	-	-	ADJ
dpc-4292	33	20	inflammatory	inflammatory	ADJ
dpc-4292	33	21	and	and	CCONJ
dpc-4292	33	22	pro	pro	ADJ
dpc-4292	33	23	-	-	ADJ
dpc-4292	33	24	angiogenic	angiogenic	ADJ
dpc-4292	33	25	mediators	mediator	NOUN
dpc-4292	33	26	like	like	ADP
dpc-4292	33	27	vegf	vegf	NOUN
dpc-4292	33	28	,	,	PUNCT
dpc-4292	33	29	whose	whose	DET
dpc-4292	33	30	role	role	NOUN
dpc-4292	33	31	has	have	AUX
dpc-4292	33	32	been	be	AUX
dpc-4292	33	33	established	establish	VERB
dpc-4292	33	34	in	in	ADP
dpc-4292	33	35	ks	ks	NOUN
dpc-4292	33	36	pathogenesis	pathogenesis	NOUN
dpc-4292	33	37	[	[	X
dpc-4292	33	38	2	2	NUM
dpc-4292	33	39	]	]	PUNCT
dpc-4292	33	40	.	.	PUNCT
dpc-4292	34	1	stallone	stallone	AUX
dpc-4292	34	2	et	et	PROPN
dpc-4292	34	3	al	al	PROPN
dpc-4292	34	4	.	.	PROPN
dpc-4292	34	5	treated	treat	VERB
dpc-4292	34	6	with	with	ADP
dpc-4292	34	7	systemic	systemic	ADJ
dpc-4292	34	8	sirolimus	sirolimus	PROPN
dpc-4292	34	9	15	15	NUM
dpc-4292	34	10	kidney	kidney	NOUN
dpc-4292	34	11	transplanted	transplant	VERB
dpc-4292	34	12	patients	patient	NOUN
dpc-4292	34	13	who	who	PRON
dpc-4292	34	14	had	have	AUX
dpc-4292	34	15	developed	develop	VERB
dpc-4292	34	16	ks	ks	NOUN
dpc-4292	34	17	during	during	ADP
dpc-4292	34	18	immunosuppressive	immunosuppressive	ADJ
dpc-4292	34	19	anti	anti	ADJ
dpc-4292	34	20	-	-	ADJ
dpc-4292	34	21	reject	reject	ADJ
dpc-4292	34	22	treatment	treatment	NOUN
dpc-4292	34	23	with	with	ADP
dpc-4292	34	24	cyclosporine	cyclosporine	NOUN
dpc-4292	34	25	.	.	PUNCT
dpc-4292	35	1	the	the	DET
dpc-4292	35	2	authors	author	NOUN
dpc-4292	35	3	showed	show	VERB
dpc-4292	35	4	that	that	SCONJ
dpc-4292	35	5	systemic	systemic	ADJ
dpc-4292	35	6	sirolimus	sirolimus	NOUN
dpc-4292	35	7	was	be	AUX
dpc-4292	35	8	effective	effective	ADJ
dpc-4292	35	9	in	in	ADP
dpc-4292	35	10	resolving	resolve	VERB
dpc-4292	35	11	ks	ks	NOUN
dpc-4292	35	12	without	without	ADP
dpc-4292	35	13	causing	cause	VERB
dpc-4292	35	14	kidney	kidney	NOUN
dpc-4292	35	15	rejection	rejection	NOUN
dpc-4292	35	16	[	[	X
dpc-4292	35	17	3	3	NUM
dpc-4292	35	18	]	]	PUNCT
dpc-4292	35	19	.	.	PUNCT
dpc-4292	36	1	in	in	ADP
dpc-4292	36	2	our	our	PRON
dpc-4292	36	3	clinical	clinical	ADJ
dpc-4292	36	4	practice	practice	NOUN
dpc-4292	36	5	,	,	PUNCT
dpc-4292	36	6	ks	ks	PROPN
dpc-4292	36	7	is	be	AUX
dpc-4292	36	8	mostly	mostly	ADV
dpc-4292	36	9	encountered	encounter	VERB
dpc-4292	36	10	in	in	ADP
dpc-4292	36	11	older	old	ADJ
dpc-4292	36	12	people	people	NOUN
dpc-4292	36	13	often	often	ADV
dpc-4292	36	14	with	with	ADP
dpc-4292	36	15	many	many	ADJ
dpc-4292	36	16	comorbidities	comorbiditie	NOUN
dpc-4292	36	17	.	.	PUNCT
dpc-4292	37	1	therefore	therefore	ADV
dpc-4292	37	2	,	,	PUNCT
dpc-4292	37	3	our	our	PRON
dpc-4292	37	4	proposed	propose	VERB
dpc-4292	37	5	approach	approach	NOUN
dpc-4292	37	6	involves	involve	VERB
dpc-4292	37	7	using	use	VERB
dpc-4292	37	8	topical	topical	ADJ
dpc-4292	37	9	sirolimus	sirolimus	NOUN
dpc-4292	37	10	0.1	0.1	NUM
dpc-4292	37	11	%	%	NOUN
dpc-4292	37	12	to	to	PART
dpc-4292	37	13	be	be	AUX
dpc-4292	37	14	applied	apply	VERB
dpc-4292	37	15	morning	morning	NOUN
dpc-4292	37	16	and	and	CCONJ
dpc-4292	37	17	evening	evening	NOUN
dpc-4292	37	18	,	,	PUNCT
dpc-4292	37	19	exerting	exert	VERB
dpc-4292	37	20	an	an	DET
dpc-4292	37	21	anti	anti	ADJ
dpc-4292	37	22	-	-	ADJ
dpc-4292	37	23	proliferative	proliferative	ADJ
dpc-4292	37	24	action	action	NOUN
dpc-4292	37	25	on	on	ADP
dpc-4292	37	26	endothelial	endothelial	ADJ
dpc-4292	37	27	cells	cell	NOUN
dpc-4292	37	28	without	without	ADP
dpc-4292	37	29	significant	significant	ADJ
dpc-4292	37	30	immunosuppression	immunosuppression	NOUN
dpc-4292	37	31	.	.	PUNCT
dpc-4292	38	1	the	the	DET
dpc-4292	38	2	small	small	ADJ
dpc-4292	38	3	cohort	cohort	NOUN
dpc-4292	38	4	patients	patient	NOUN
dpc-4292	38	5	is	be	AUX
dpc-4292	38	6	the	the	DET
dpc-4292	38	7	main	main	ADJ
dpc-4292	38	8	limitation	limitation	NOUN
dpc-4292	38	9	of	of	ADP
dpc-4292	38	10	this	this	DET
dpc-4292	38	11	study	study	NOUN
dpc-4292	38	12	,	,	PUNCT
dpc-4292	38	13	but	but	CCONJ
dpc-4292	38	14	the	the	DET
dpc-4292	38	15	rationale	rationale	NOUN
dpc-4292	38	16	is	be	AUX
dpc-4292	38	17	wellfounded	wellfounde	VERB
dpc-4292	38	18	on	on	ADP
dpc-4292	38	19	the	the	DET
dpc-4292	38	20	literature	literature	NOUN
dpc-4292	38	21	and	and	CCONJ
dpc-4292	38	22	clinical	clinical	ADJ
dpc-4292	38	23	practice	practice	NOUN
dpc-4292	38	24	.	.	PUNCT
dpc-4292	39	1	more	more	ADJ
dpc-4292	39	2	studies	study	NOUN
dpc-4292	39	3	need	need	VERB
dpc-4292	39	4	to	to	PART
dpc-4292	39	5	demonstrate	demonstrate	VERB
dpc-4292	39	6	the	the	DET
dpc-4292	39	7	efficacy	efficacy	NOUN
dpc-4292	39	8	and	and	CCONJ
dpc-4292	39	9	safety	safety	NOUN
dpc-4292	39	10	of	of	ADP
dpc-4292	39	11	sirolimus	sirolimus	NOUN
dpc-4292	39	12	0.1	0.1	NUM
dpc-4292	39	13	%	%	NOUN
dpc-4292	39	14	in	in	ADP
dpc-4292	39	15	the	the	DET
dpc-4292	39	16	management	management	NOUN
dpc-4292	39	17	of	of	ADP
dpc-4292	39	18	mediterranean	mediterranean	PROPN
dpc-4292	39	19	ks	ks	PROPN
dpc-4292	39	20	.	.	PROPN
dpc-4292	39	21	references	reference	NOUN
dpc-4292	39	22	1	1	NUM
dpc-4292	39	23	.	.	PUNCT
dpc-4292	39	24	schneider	schneider	PROPN
dpc-4292	39	25	jw	jw	PROPN
dpc-4292	39	26	,	,	PUNCT
dpc-4292	39	27	dittmer	dittmer	PROPN
dpc-4292	39	28	dp	dp	PROPN
dpc-4292	39	29	.	.	PUNCT
dpc-4292	39	30	diagnosis	diagnosis	NOUN
dpc-4292	39	31	and	and	CCONJ
dpc-4292	39	32	treatment	treatment	NOUN
dpc-4292	39	33	of	of	ADP
dpc-4292	39	34	kaposi	kaposi	PROPN
dpc-4292	39	35	sarcoma	sarcoma	PROPN
dpc-4292	39	36	.	.	PUNCT
dpc-4292	40	1	am	be	AUX
dpc-4292	40	2	j	j	PROPN
dpc-4292	40	3	clin	clin	PROPN
dpc-4292	40	4	dermatol	dermatol	NOUN
dpc-4292	40	5	.	.	PUNCT
dpc-4292	41	1	2017	2017	NUM
dpc-4292	41	2	aug;18(4):529	aug;18(4):529	ADV
dpc-4292	41	3	-	-	PUNCT
dpc-4292	41	4	539	539	NUM
dpc-4292	41	5	.	.	PUNCT
dpc-4292	42	1	doi	doi	NOUN
dpc-4292	42	2	:	:	PUNCT
dpc-4292	42	3	10.1007	10.1007	NUM
dpc-4292	42	4	/	/	SYM
dpc-4292	42	5	s40257	s40257	NOUN
dpc-4292	42	6	-	-	PUNCT
dpc-4292	42	7	017	017	NUM
dpc-4292	42	8	-	-	PUNCT
dpc-4292	42	9	0270	0270	NUM
dpc-4292	42	10	-	-	PUNCT
dpc-4292	42	11	4	4	NUM
dpc-4292	42	12	.	.	PUNCT
dpc-4292	43	1	pmid	pmid	NOUN
dpc-4292	43	2	:	:	PUNCT
dpc-4292	43	3	28324233	28324233	NUM
dpc-4292	43	4	;	;	PUNCT
dpc-4292	43	5	pmcid	pmcid	NOUN
dpc-4292	43	6	:	:	PUNCT
dpc-4292	43	7	pmc	pmc	PROPN
dpc-4292	43	8	5509489	5509489	NUM
dpc-4292	43	9	.	.	PUNCT
dpc-4292	44	1	2	2	X
dpc-4292	44	2	.	.	X
dpc-4292	44	3	kang	kang	PROPN
dpc-4292	44	4	t	t	PROPN
dpc-4292	44	5	,	,	PUNCT
dpc-4292	44	6	ye	ye	PROPN
dpc-4292	44	7	fc	fc	PROPN
dpc-4292	44	8	,	,	PUNCT
dpc-4292	44	9	gao	gao	PROPN
dpc-4292	44	10	sj	sj	PROPN
dpc-4292	44	11	,	,	PUNCT
dpc-4292	44	12	wang	wang	PROPN
dpc-4292	44	13	ld	ld	PROPN
dpc-4292	44	14	.	.	PROPN
dpc-4292	44	15	angiogenesis	angiogenesis	PROPN
dpc-4292	44	16	,	,	PUNCT
dpc-4292	44	17	kaposi	kaposi	PROPN
dpc-4292	44	18	’s	’s	PART
dpc-4292	44	19	sarcoma	sarcoma	NOUN
dpc-4292	44	20	and	and	CCONJ
dpc-4292	44	21	kaposi	kaposi	PROPN
dpc-4292	44	22	’s	’s	PART
dpc-4292	44	23	sarcoma	sarcoma	NOUN
dpc-4292	44	24	-	-	PUNCT
dpc-4292	44	25	associated	associate	VERB
dpc-4292	44	26	herpesvirus	herpesvirus	NOUN
dpc-4292	44	27	.	.	PUNCT
dpc-4292	45	1	virol	virol	NOUN
dpc-4292	45	2	sin	sin	PROPN
dpc-4292	45	3	.	.	PUNCT
dpc-4292	46	1	2008	2008	NUM
dpc-4292	46	2	dec	dec	PROPN
dpc-4292	46	3	1;23(6):449	1;23(6):449	NUM
dpc-4292	46	4	-	-	SYM
dpc-4292	46	5	458	458	NUM
dpc-4292	46	6	.	.	PUNCT
dpc-4292	47	1	doi	doi	NOUN
dpc-4292	47	2	:	:	PUNCT
dpc-4292	47	3	10.1007	10.1007	NUM
dpc-4292	47	4	/	/	SYM
dpc-4292	47	5	s12250	s12250	PROPN
dpc-4292	47	6	-	-	PUNCT
dpc-4292	47	7	008	008	NUM
dpc-4292	47	8	-	-	PUNCT
dpc-4292	47	9	2998	2998	NUM
dpc-4292	47	10	-	-	SYM
dpc-4292	47	11	8	8	NUM
dpc-4292	47	12	.	.	PUNCT
dpc-4292	48	1	pmid	pmid	NOUN
dpc-4292	48	2	:	:	PUNCT
dpc-4292	48	3	19890492	19890492	NUM
dpc-4292	48	4	;	;	PUNCT
dpc-4292	48	5	pmcid	pmcid	ADJ
dpc-4292	48	6	:	:	PUNCT
dpc-4292	48	7	pmc2771944	pmc2771944	NOUN
dpc-4292	48	8	.	.	PUNCT
dpc-4292	49	1	3	3	X
dpc-4292	49	2	.	.	X
dpc-4292	49	3	stallone	stallone	NOUN
dpc-4292	49	4	g	g	PROPN
dpc-4292	49	5	,	,	PUNCT
dpc-4292	49	6	infante	infante	PROPN
dpc-4292	49	7	b	b	PROPN
dpc-4292	49	8	,	,	PUNCT
dpc-4292	49	9	grandaliano	grandaliano	VERB
dpc-4292	49	10	g	g	NOUN
dpc-4292	49	11	,	,	PUNCT
dpc-4292	49	12	schena	schena	NOUN
dpc-4292	49	13	fp	fp	PROPN
dpc-4292	49	14	,	,	PUNCT
dpc-4292	49	15	gesualdo	gesualdo	PROPN
dpc-4292	49	16	l.	l.	PROPN
dpc-4292	49	17	kaposi	kaposi	PROPN
dpc-4292	49	18	’s	’s	PART
dpc-4292	49	19	sarcoma	sarcoma	NOUN
dpc-4292	49	20	and	and	CCONJ
dpc-4292	49	21	mtor	mtor	PROPN
dpc-4292	49	22	:	:	PUNCT
dpc-4292	49	23	a	a	DET
dpc-4292	49	24	crossroad	crossroad	NOUN
dpc-4292	49	25	between	between	ADP
dpc-4292	49	26	viral	viral	ADJ
dpc-4292	49	27	infection	infection	NOUN
dpc-4292	49	28	neoangiogenesis	neoangiogenesis	NOUN
dpc-4292	49	29	and	and	CCONJ
dpc-4292	49	30	immunosuppression	immunosuppression	NOUN
dpc-4292	49	31	.	.	PUNCT
dpc-4292	50	1	transpl	transpl	NOUN
dpc-4292	50	2	int	int	PROPN
dpc-4292	50	3	.	.	PUNCT
dpc-4292	51	1	2008	2008	NUM
dpc-4292	51	2	sep;21(9):825	sep;21(9):825	SYM
dpc-4292	51	3	-	-	SYM
dpc-4292	51	4	32	32	NUM
dpc-4292	51	5	.	.	PUNCT
dpc-4292	52	1	doi	doi	NOUN
dpc-4292	52	2	:	:	PUNCT
dpc-4292	52	3	10.1111	10.1111	NUM
dpc-4292	52	4	/	/	SYM
dpc-4292	52	5	j.1432	j.1432	NOUN
dpc-4292	52	6	-	-	PUNCT
dpc-4292	52	7	2277.2008.00697.x	2277.2008.00697.x	NOUN
dpc-4292	52	8	.	.	PUNCT
dpc-4292	53	1	epub	epub	NOUN
dpc-4292	53	2	2008	2008	NUM
dpc-4292	53	3	may	may	PROPN
dpc-4292	53	4	22	22	NUM
dpc-4292	53	5	.	.	PUNCT
dpc-4292	54	1	pmid	pmid	NOUN
dpc-4292	54	2	:	:	PUNCT
dpc-4292	54	3	18498314	18498314	NUM
dpc-4292	54	4	.	.	PUNCT
dpc-4292	55	1	figure	figure	NOUN
dpc-4292	55	2	1	1	NUM
dpc-4292	55	3	.	.	SYM
dpc-4292	55	4	79	79	NUM
dpc-4292	55	5	-	-	PUNCT
dpc-4292	55	6	year	year	NOUN
dpc-4292	55	7	-	-	PUNCT
dpc-4292	55	8	old	old	ADJ
dpc-4292	55	9	female	female	ADJ
dpc-4292	55	10	patient	patient	NOUN
dpc-4292	55	11	’s	’s	PART
dpc-4292	55	12	left	leave	VERB
dpc-4292	55	13	foot	foot	NOUN
dpc-4292	55	14	.	.	PUNCT
dpc-4292	56	1	(	(	PUNCT
dpc-4292	56	2	a	a	X
dpc-4292	56	3	)	)	PUNCT
dpc-4292	56	4	panel	panel	NOUN
dpc-4292	56	5	shows	show	VERB
dpc-4292	56	6	a	a	DET
dpc-4292	56	7	large	large	ADJ
dpc-4292	56	8	red	red	ADJ
dpc-4292	56	9	-	-	PUNCT
dpc-4292	56	10	purplish	purplish	NOUN
dpc-4292	56	11	infiltrated	infiltrate	VERB
dpc-4292	56	12	plaque	plaque	NOUN
dpc-4292	56	13	,	,	PUNCT
dpc-4292	56	14	confirmed	confirm	VERB
dpc-4292	56	15	as	as	ADP
dpc-4292	56	16	ks	k	NOUN
dpc-4292	56	17	by	by	ADP
dpc-4292	56	18	an	an	DET
dpc-4292	56	19	incisional	incisional	ADJ
dpc-4292	56	20	biopsy	biopsy	NOUN
dpc-4292	56	21	.	.	PUNCT
dpc-4292	57	1	(	(	PUNCT
dpc-4292	57	2	b	b	X
dpc-4292	57	3	)	)	PUNCT
dpc-4292	57	4	panel	panel	NOUN
dpc-4292	57	5	shows	show	VERB
dpc-4292	57	6	the	the	DET
dpc-4292	57	7	same	same	ADJ
dpc-4292	57	8	foot	foot	NOUN
dpc-4292	57	9	after	after	ADP
dpc-4292	57	10	six	six	NUM
dpc-4292	57	11	month	month	NOUN
dpc-4292	57	12	of	of	ADP
dpc-4292	57	13	sirolimus	sirolimus	NOUN
dpc-4292	57	14	0.1	0.1	NUM
dpc-4292	57	15	%	%	NOUN
dpc-4292	57	16	in	in	ADP
dpc-4292	57	17	pentravan	pentravan	NOUN
dpc-4292	57	18	®	®	NOUN
dpc-4292	57	19	applied	apply	VERB
dpc-4292	57	20	morning	morning	NOUN
dpc-4292	57	21	and	and	CCONJ
dpc-4292	57	22	evening	evening	NOUN
dpc-4292	57	23	.	.	PUNCT
dpc-4292	58	1	at	at	ADP
dpc-4292	58	2	clinical	clinical	ADJ
dpc-4292	58	3	examination	examination	NOUN
dpc-4292	58	4	,	,	PUNCT
dpc-4292	58	5	the	the	DET
dpc-4292	58	6	infiltration	infiltration	NOUN
dpc-4292	58	7	has	have	AUX
dpc-4292	58	8	almost	almost	ADV
dpc-4292	58	9	disappeared	disappear	VERB
dpc-4292	58	10	,	,	PUNCT
dpc-4292	58	11	while	while	SCONJ
dpc-4292	58	12	hyperpigmentation	hyperpigmentation	NOUN
dpc-4292	58	13	persists	persist	VERB
dpc-4292	58	14	.	.	PUNCT